Business · 10/11/2010
FDA Reopens Comment Period for Prescription Drug User Fee Act Reauthorization
The FDA is extending the public comment period for the Prescription Drug User Fee Act (PDUFA) reauthorization until October 31, 2011, to gather input from stakeholders on the proposed changes to the human drug review program.
Original source language: Federal Register — Health and Human ServicesOpen original release →